Indications of Cipro-A Ophthalmic Solution

Ciprofloxacin 0.3 percent Eye/Ear Drops is used to treat infections caused by susceptible strains of the following bacteria in the following conditions:

Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae are some of the bacteria that cause corneal ulcers.

Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Bacterial Conjunctivitis It’s also used to treat keratitis, keratoconjunctivitis, blepharitis, blepharo-conjunctivitis, and dacryocistitis, as well as to prevent ocular infections caused by Neisseria gonorrhea or Chlamydia trachomatis, and to prevent ocular infections after removing a corneal or physical agent before or after ocular surgery.

Otitis externa, acute otitis media, chronic suppurative otitis media are all conditions that affect the ear. Otic surgery, such as mastoid surgery, requires prophylaxis.

Pharmacology of Cipro-A Ophthalmic Solution

Ciprofloxacin is a broad-spectrum antibacterial drug that is administered intravenously. Ciprofloxacin’s bactericidal effect is due to suppression of the topoisomerase II (DNA gyrase) and topoisomerase IV enzymes, which are necessary for bacterial DNA replication, transcription, repair, and recombination.

Dosage & Administration of Cipro-A Ophthalmic Solution

Corneal ulcers: The recommended dosage regimen for the treatment of corneal ulcers is two drops into the affected eye every 15 minutes for the first 6 hours and then two drops into the affected eye every 30 minutes for the remainder of the first day. On the second day, instill 2 drops in the affected eye hourly. On the third through the fourteenth day, place two drops in the affected eye every four hours. Treatment may be continued after 14 days if corneal re-epithelization has not been occurred.

Bacterial conjunctivitis: The recommended dosage regimen for the treatment of bacterial conjunctivitis is one or two drops instilled into the conjunctival sac(s) every two hours while awake for two days and one or two drops every four hours while awake for the next five days.

Ear infections: For all infections, 2-3 drops every 2-3 hours initially, reducing the frequency of the instillation with control of infection. Treatment should be continued at least 7 days.

Interaction of Cipro-A Ophthalmic Solution

With ophthalmic Ciprofloxacin, no specific medication interaction studies have been found.

Contraindications

Hypersensitivity to the quinolone antibacterial group or any of the formulation’s components.

Side Effects of Cipro-A Ophthalmic Solution

Following administration, you may experience local burning or discomfort, itching, a foreign body sensation, crystalline precipitates, lid border crusting, conjunctival hyperemia, and a poor taste. It’s possible that you’ll have photophobia and nausea.

Pregnancy & Lactation

If the potential benefits outweigh the potential risk during pregnancy, don’t use it. It is unknown whether topical ophthalmic administration causes excretion in human milk. Nursing mothers should be treated with caution.

Precautions & Warnings

Ciprofloxacin use in the eyes for a long time can cause non-susceptible organisms, such as fungus, to overgrow. Ciprofloxacin should be stopped as soon as a skin rash or other evidence of hypersensitivity reaction appears.

Therapeutic Class

Aural Anti-bacterial preparations, Ophthalmic antibacterial drugs

Storage Conditions

Store below 30° C in a cold, dry, and light-protected location. Keep out of children’s reach. Because touching the dropper tip to surfaces can contaminate the solution, avoid doing so. After 30 days from the date of initial opening, do not use.

Pharmaceutical Name of Cipro-A Ophthalmic Solution

ACME Laboratories Ltd

Generic of Cipro-A Ophthalmic Solution

Ciprofloxacin